{
    "cancelStatus": "1",
    "cancelDate": "2012-11-26",
    "cancelReason": [
        "838"
    ],
    "licid": "06015905",
    "validDate": "2011-01-17 00:00:00.000",
    "issueDate": "2006-01-17 00:00:00.000",
    "licKind": "09",
    "oldLicid": null,
    "certNo": "DHAS0601590506",
    "prodNameC": "常盈胰島素檢驗試劑",
    "prodNameE": "DSL Insulin RIA",
    "indicationsName": [],
    "does": null,
    "packageUnit": [],
    "medMCode": null,
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "A. Insulin Standards:\\n     One vial, labeled A, containing 0 μIU\/mL and five vials, labeled B-F, containing concentrations of approximately 5, 15, 50, 150 and 300 μIU\/mL (0.2-12 ng\/mL) of insulin in a protein-based buffer with sodium azide as a preservative.\\nB. Insulin I-125 Reagent: \\n     One vial, containing < 5 μCi (185 kBq) of I-125-labeled insulin in a protein-based buffer with sodium azide as a preservative.\\nC. Insulin Antiserum: \\n     One vial, containing guinea-pig anti-insulin serum with sodium azide as a preservative.\\nD. Precipitating Reagent:\\n     One bottle, 105 mL, containing goat anti-guinea pig gamma globulin serum with polyethylene glycol as a precipitating aid and sodium azide as a preservative.\\nE. Insulin Controls:\\n     Two vials, Level I and II, containing a low and high level of insulin in a protein-based buffer with sodium azide as a preservative.\\n\\n"
    ],
    "restraintItemsCode": [
        "R02",
        "R94"
    ],
    "applicantName": "常盈實業股份有限公司",
    "applicantAddr": "台北市北投區永興路一段49號",
    "medClass": "2",
    "efficacy": "利用放射性免疫定量方法檢測血清或血漿中的胰島素。 ",
    "mdFormat": "DSL-1600: 100 tubes",
    "productAnnotation": null,
    "mdKind": [
        {
            "mdKindMCode": "A",
            "mdKindMCodeName": "A 臨床化學及臨床毒理學",
            "mdKindDCode": "A.1405",
            "mdKindDCodeName": "A.1405 免疫反應胰島素試驗系統",
            "checkChange": "Y"
        }
    ],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "DIAGNOSTIC SYSTEMS LABORATORIES, INC.",
            "factoryAddr": "445 MEDICAL CENTER BOULEVARD WEBSTER, TEXAS 77598 U.S.A.",
            "factoryCompanyAddr": null,
            "countryCode": "US",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "MUS1077000",
            "factoryInfo": "1",
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "A. Insulin Standards:\\n     One vial, labeled A, containing 0 μIU\/mL and five vials, labeled B-F, containing concentrations of approximately 5, 15, 50, 150 and 300 μIU\/mL (0.2-12 ng\/mL) of insulin in a protein-based buffer with sodium azide as a preservative.\\nB. Insulin I-125 Reagent: \\n     One vial, containing < 5 μCi (185 kBq) of I-125-labeled insulin in a protein-based buffer with sodium azide as a preservative.\\nC. Insulin Antiserum: \\n     One vial, containing guinea-pig anti-insulin serum with sodium azide as a preservative.\\nD. Precipitating Reagent:\\n     One bottle, 105 mL, containing goat anti-guinea pig gamma globulin serum with polyethylene glycol as a precipitating aid and sodium azide as a preservative.\\nE. Insulin Controls:\\n     Two vials, Level I and II, containing a low and high level of insulin in a protein-based buffer with sodium azide as a preservative.\\n\\n",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": []
}